GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (XSAT:ENZY) » Definitions » Other Long Term Assets

Enzymatica AB (XSAT:ENZY) Other Long Term Assets : kr2.70 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Enzymatica AB Other Long Term Assets?

Enzymatica AB's other long-term assets for the quarter that ended in Mar. 2024 was kr2.70 Mil.

Enzymatica AB's quarterly other long-term assets increased from Sep. 2023 (kr2.30 Mil) to Dec. 2023 (kr2.31 Mil) and increased from Dec. 2023 (kr2.31 Mil) to Mar. 2024 (kr2.70 Mil).

Enzymatica AB's annual other long-term assets increased from Dec. 2021 (kr2.12 Mil) to Dec. 2022 (kr2.32 Mil) but then declined from Dec. 2022 (kr2.32 Mil) to Dec. 2023 (kr2.31 Mil).

Enzymatica AB Other Long Term Assets Historical Data

The historical data trend for Enzymatica AB's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymatica AB Other Long Term Assets Chart

Enzymatica AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.17 1.71 2.12 2.32 2.31

Enzymatica AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.21 2.34 2.30 2.31 2.70

Enzymatica AB Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Enzymatica AB (XSAT:ENZY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (XSAT:ENZY) » Definitions » Other Long Term Assets
Comparable Companies
OSTO:ORX XSAT:EQL OSTO:ALZCUR OSTO:MOB OSTO:ERMA OSTO:CRNO B OSTO:VIVE XSAT:PMED XSAT:ODI XSAT:DICOT ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ENZY:Sweden EN9:Germany
Address
Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Website
http://www.enzymatica.se
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

Enzymatica AB (XSAT:ENZY) Headlines

From GuruFocus

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson • 12-07-2015

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi • 12-20-2016

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon • 07-01-2016